161 related articles for article (PubMed ID: 29390362)
1. Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report.
Corrias G; Horvat N; Monti S; Basturk O; Lin O; Saba L; Bodei L; Reidy DL; Mannelli L
Medicine (Baltimore); 2017 Dec; 96(50):e9252. PubMed ID: 29390362
[TBL] [Abstract][Full Text] [Related]
2. Metastatic glucagonoma: treatment with liver transplantation.
Radny P; Eigentler TK; Soennichsen K; Overkamp D; Raab HR; Viebahn R; Mueller-Horvart C; Sotlar K; Rassner G
J Am Acad Dermatol; 2006 Feb; 54(2):344-7. PubMed ID: 16443073
[TBL] [Abstract][Full Text] [Related]
3. Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.
Dal Coleto CC; de Mello AP; Piquero-Casals J; Lima FR; Vilela MA; Festa-Neto C; Sanches JA
Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(6):183-8. PubMed ID: 11836542
[TBL] [Abstract][Full Text] [Related]
4. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
5. Malign cystic glucagonoma presented with diabetic ketoacidosis: case report with an update.
Fenkci SM; Fidan Yaylali G; Sermez Y; Akdam H; Sabir N; Kiraç S
Endocr Relat Cancer; 2005 Jun; 12(2):449-54. PubMed ID: 15947115
[TBL] [Abstract][Full Text] [Related]
6. Necrolytic Migratory Erythema: Complete Healing after Surgical Removal of Pancreatic Carcinoma.
V'lckova-Laskoska M; Balabanova-Stefanova M; Arsovska-Bezhoska I; Caca-Biljanovska N; Laskoski D
Acta Dermatovenerol Croat; 2018 Dec; 26(4):329-332. PubMed ID: 30665484
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.
Mavi ME; Tuncel M
Clin Nucl Med; 2021 Dec; 46(12):1002-1003. PubMed ID: 34034327
[TBL] [Abstract][Full Text] [Related]
8. Glucagonoma syndrome with atypical necrolytic migratory erythema.
He S; Zeng W; Geng S; Jia J
Indian J Dermatol Venereol Leprol; 2021; 87(1):49-53. PubMed ID: 31368453
[TBL] [Abstract][Full Text] [Related]
9. [Radiodiagnosis of glucagonoma and vipoma, 2 rare endocrine pancreatic tumors].
de Win JL; Rosenbusch G; Lamers CB; Boetes C; de Boer HH; van Tongeren JH
Rofo; 1984 May; 140(5):537-44. PubMed ID: 6330802
[TBL] [Abstract][Full Text] [Related]
10. Necrolytic migratory erythema and pancreatic glucagonoma.
Rodríguez G; Vargas E; Abaúnza C; Cáceres S
Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
[TBL] [Abstract][Full Text] [Related]
11. Glucagonoma syndrome with severe erythematous rash: A rare case report.
Wang ZX; Wang F; Zhao JG
Medicine (Baltimore); 2019 Sep; 98(37):e17158. PubMed ID: 31517863
[TBL] [Abstract][Full Text] [Related]
12. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
13. Glucagonoma syndrome and necrolytic migratory erythema.
Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
[TBL] [Abstract][Full Text] [Related]
14. Primary malignant hepatic glucagonoma: an autopsy case.
Obi N; Katabami T; Obi R; Odanaka M; Sasano K; Tanaka Y
Endocr J; 2009; 56(5):715-9. PubMed ID: 19367016
[TBL] [Abstract][Full Text] [Related]
15. [Glucagonoma: case report and literature review].
das Neves MM; Martins Júnior EV; Gaburri AK; Chebli JM; Stávale JN; Herani Filho AK
Arq Gastroenterol; 1996; 33(3):167-72. PubMed ID: 9201330
[TBL] [Abstract][Full Text] [Related]
16. A case of glucagonoma with high uptake on F-18 fluorodeoxyglucose positron emission tomography.
Nishiguchi S; Shiomi S; Ishizu H; Iwata Y; Kurooka H; Minamitani S; Habu D; Kawabe J; Ochi H
Ann Nucl Med; 2001 Jun; 15(3):259-62. PubMed ID: 11545198
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of subclinical diffuse glucagonoma coexisting with two nodules in the pancreas: characteristic features on computed tomography.
Azemoto N; Kumagi T; Yokota T; Kuroda T; Koizumi M; Yamanishi H; Soga Y; Furukawa S; Abe M; Ikeda Y; Hiasa Y; Matsuura B; Watanabe J; Kushihata F; Onji M
Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):e43-7. PubMed ID: 22239827
[TBL] [Abstract][Full Text] [Related]
18. Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.
Kimbara S; Fujiwara Y; Toyoda M; Chayahara N; Imamura Y; Kiyota N; Mukohara T; Fukunaga A; Oka M; Nishigori C; Minami H
Clin J Gastroenterol; 2014 Jun; 7(3):255-9. PubMed ID: 26183746
[TBL] [Abstract][Full Text] [Related]
19. Current imaging and possible therapeutic management of glucagonoma tumors: a case report.
Johnson DS; Coel MN; Bornemann M
Clin Nucl Med; 2000 Feb; 25(2):120-2. PubMed ID: 10656647
[TBL] [Abstract][Full Text] [Related]
20. Glucagonoma syndrome: a case report.
Shyr YM; Su CH; Lee CH; Wu CW; Lui WY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):639-43. PubMed ID: 10502856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
